台股 » 個股 » 國光生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

國光生

(4142)
可現股當沖
  • 股價
    28.10
  • 漲跌
    ▼0.15
  • 漲幅
    -0.53%
  • 成交量
    739
  • 產業
    上市 生技醫療類股
  • 633人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
國光生 (4142)籌碼相關-富邦-二林 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-二林 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/0800.00128.3028.10-11,120-0.09%
2024/05/0600.00228.2028.20-21,115-0.18%
2024/05/0300.00127.6527.60-11,100-0.09%
2024/04/29227.3000.0027.5521,0990.18%
2024/04/24127.2500.0027.2011,0960.09%
2024/04/23226.9800.0027.1021,1050.18%
2024/04/19327.45127.2527.3521,1000.18%
2024/04/1810429.87329.1828.501011,0739.41% 大買/鉅額交易
2024/04/1700.00227.8027.80-2963-0.21%
2024/04/12126.60126.6026.5509100.00%
2024/04/02126.7500.0026.6019450.11%
2024/03/25126.8000.0026.7519910.10%
2024/03/0500.000.128.8028.90-0.11,084-0.01%
2024/02/26129.9500.0029.9511,2210.08%
2024/02/23230.030.230.2130.001.91,2220.15%
2024/02/2200.00230.4530.45-21,220-0.16%
2024/02/2100.001730.0430.00-171,213-1.40%
2024/02/0100.00130.4030.30-11,039-0.10%
2024/01/25131.1000.0031.1011,0350.10%
2024/01/22231.1000.0031.0021,0350.19%
2024/01/1700.00431.1031.10-41,036-0.39%
2024/01/031633.4000.0033.00161,0221.56%
2023/12/25132.5000.0032.5519770.10%
2023/12/1800.000.133.0533.00-0.1987-0.01%
2023/12/15132.8000.0032.5011,0000.10%
2023/12/11433.5800.0033.2049830.41%
2023/12/06335.1000.0035.0539820.31%
2023/12/0400.00136.5036.05-1953-0.10%
2023/12/0100.00336.3035.80-3920-0.33%
2023/11/300.135.70235.6035.70-1.9902-0.21%
2023/11/2900.00535.7035.95-5888-0.56%
2023/11/2800.00235.5535.65-2880-0.23%
2023/11/271035.251235.5036.00-2845-0.24%
2023/11/2000.00133.1033.00-1745-0.13%
2023/11/10232.4500.0032.3027480.27%
2023/11/09132.5000.0032.4017440.13%
2023/11/0800.00132.4532.45-1758-0.13%
2023/11/07232.7800.0032.4027600.26%
2023/10/30232.4000.0032.1027750.26%
2023/10/17232.6500.0032.2028060.25%
2023/10/13133.0000.0032.8518620.12%
2023/10/1100.00133.8533.85-1862-0.12%
2023/09/28534.2000.0034.1058870.56%
2023/09/2600.00634.7334.50-6901-0.67%
2023/09/21234.2500.0034.5028950.22%
2023/09/19333.9200.0033.7038680.35%
2023/09/18234.0500.0034.4028620.23%
2023/09/110.133.55432.8433.35-3.9855-0.46%
2023/08/31233.6000.0033.1528750.23%
2023/08/2500.00133.2033.00-1872-0.11%
2023/08/23332.40132.6532.2028530.23%
2023/08/18132.7500.0032.5018630.12%
2023/08/16132.3000.0032.3018780.11%
2023/08/0800.00134.0034.00-1879-0.11%
2023/08/04134.3000.0034.2519170.11%
2023/08/0100.00135.0535.00-1919-0.11%
2023/07/3100.00135.3035.05-1921-0.11%
2023/07/21436.1800.0035.6049510.42%
2023/07/20236.4000.0036.2029600.21%
2023/07/19536.94137.9036.8049790.41%
2023/07/18135.30235.4335.20-1960-0.10%
2023/07/17535.9700.0035.8059700.52%
2023/07/14335.3500.0035.4039840.30%
2023/07/06137.0000.0036.7511,0550.09%
2023/06/29137.4000.0037.4511,0710.09%
2023/06/26237.1500.0037.1021,0820.18%
2023/06/0500.004338.3738.35-432,134-2.01%
2023/05/181037.5100.0037.50102,2890.44%
2023/05/10238.6000.0038.6022,3970.08%
2023/05/0800.00240.1039.95-22,587-0.08%
2023/04/19240.3500.0040.5022,8610.07%
2023/04/18141.25140.7540.7502,8440.00%
2023/04/14140.70140.4540.4502,8020.00%
2023/04/13140.6000.0040.1512,7850.04%
國光生去年營運轉虧 今年拚重回成長軌道Anue鉅亨-2024/03/13
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
國光生 相關文章